As HPV-vaccinated cohorts age into screening eligibility, researchers evaluated how cervical cancer screening intensity could be tailored by age at vaccination and vaccine type to balance benefits, harms,...
A new randomized trial in newly formed heterosexual couples investigated whether recent human papillomavirus vaccination protects individuals or their partners against transmission.
A multilevel intervention improved human papillomavirus vaccine initiation and completion among most children aged 11 to 12 years, though the effect was limited for those living in under-resourced settings,...
Researchers evaluated the effects of receiving the human papilloma virus vaccine on risk of developing high‐grade cervical intraepithelial neoplasia among 2 cohorts of women born in 1993 and 1983.
The American Cancer Society has released an update to its guidelines for human papillomavirus vaccination, based on recommendations released in 2019 by the ACIP.
Researchers conducted a retrospective matched cohort study involving 132,000 young women in order to evaluate the effects of various dosages of the HPV vaccination on the risk of developing cervical...
The HPV vaccine is recommended for preventing anogenital HPV infections. Now, findings from a recent study suggest the vaccine can provide herd immunity among unvaccinated men against vaccine-type oral HPV...
HPV is the most common STI around the world, and new research suggests certain forms of the infection may serve as yet another significant risk factor for cardiovascular disease.
